Triazavirin is the first medicine in the azoloazine group and the pioneer of this class of drugs. It is effective against over 15 strains of influenza and fevers, including swine and avian ones. Also, against a number of dangerous pathogenic viruses like Dengue and West Nile fever, tick-borne encephalitis, and other dangerous infections.

In late December 2019, an outbreak of an emerging disease (COVID-19) because of a novel coronavirus started in Wuhan, China and rapidly spread across the globe. To date, there is no medical drug for the treatment of coronavirus. The severe emergency caused by the epidemic allowed clinicians to use antiviral drugs, despite the lack of evidence.

What is immunity? Generally, it is the body’s internal capability that helps it fight infection. However, it is not as simple as it seems. Immunity is one of the most complex and intricate systems in the human body that has been developed throughout the evolution of mankind.

You might notice that viruses and the immune system are of high interest lately. And not without a reason... So we've prepared some new products to help your immunity to fight with viruses and other enemies from outer space.

Nowadays, it's popular not to just treat mental diseases using nootropics, but also to practice biohacking by healthy individuals. However, we should understand that there may be some risks of using nootropics, which means that we have to be as conscious as possible while applying such preparations.

Nowadays the problem of treating influenza and other viral diseases is extremely urgent, because they make up an impressive share of all infectious diseases. Every year in the winter months, influenza spreads over several continents. According to the World Health Organization (WHO), 5–10% of adults and 20–30% of children suffer from influenza every year, while terminal episodes amount to around 250–500 thousand people. Fortunately, the human body is equipped with the immune system, a means of protection against foreign microorganisms. The difficulty lies in the fact that it takes the system several days to develop "weapons", interferons and antibodies, in quantities sufficient to struggle with the disease.

The pharmaceutical industry is attempting to help the immune system accelerate recovery, reduce the effects of infection, and prevent morbidity. The Soviet Union began the development of a broad-spectrum antiviral drug capable of suppressing influenza and other acute respiratory viral infections (ARVI) in the middle of the last century. In 1974 scientists of the All-Union Scientific Research Chemical-Pharmaceutical Institute, Institute of Medical Radiology of the USSR Academy of Medical Sciences and the Leningrad Bacteriological and Diagnostic Institute developed an antiviral drug ARBIDOL®.